Viewing Study NCT02325050


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-01-24 @ 5:52 AM
Study NCT ID: NCT02325050
Status: COMPLETED
Last Update Posted: 2017-06-14
First Post: 2014-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants
Sponsor: Janssen Vaccines & Prevention B.V.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module